Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Autologous_patient_specific_tumor_antigen_response> ?p ?o. }
Showing items 1 to 24 of
24
with 100 items per page.
- Autologous_patient_specific_tumor_antigen_response abstract "Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology.Also known as laser-assisted immunotherapy, apSTAR is an experimental cancer treatment for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses. Specifically, laser-assisted immunotherapy combines laser-induced in situ tumor devitalization with an immunoadjuvant for local immunostimulation. Experimental data and initial human trials suggests that laser-assisted immunotherapy treatment may prolong life and even cure patients with advanced cancer.".
- Autologous_patient_specific_tumor_antigen_response wikiPageExternalLink www.VetCancer.com.
- Autologous_patient_specific_tumor_antigen_response wikiPageID "24780693".
- Autologous_patient_specific_tumor_antigen_response wikiPageRevisionID "590720833".
- Autologous_patient_specific_tumor_antigen_response hasPhotoCollection Autologous_patient_specific_tumor_antigen_response.
- Autologous_patient_specific_tumor_antigen_response subject Category:Cancer_treatments.
- Autologous_patient_specific_tumor_antigen_response type Abstraction100002137.
- Autologous_patient_specific_tumor_antigen_response type Act100030358.
- Autologous_patient_specific_tumor_antigen_response type Activity100407535.
- Autologous_patient_specific_tumor_antigen_response type CancerTreatments.
- Autologous_patient_specific_tumor_antigen_response type Care100654885.
- Autologous_patient_specific_tumor_antigen_response type Event100029378.
- Autologous_patient_specific_tumor_antigen_response type PsychologicalFeature100023100.
- Autologous_patient_specific_tumor_antigen_response type Treatment100658082.
- Autologous_patient_specific_tumor_antigen_response type Work100575741.
- Autologous_patient_specific_tumor_antigen_response type YagoPermanentlyLocatedEntity.
- Autologous_patient_specific_tumor_antigen_response comment "Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology.Also known as laser-assisted immunotherapy, apSTAR is an experimental cancer treatment for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses.".
- Autologous_patient_specific_tumor_antigen_response label "Autologous patient specific tumor antigen response".
- Autologous_patient_specific_tumor_antigen_response sameAs m.0809zpb.
- Autologous_patient_specific_tumor_antigen_response sameAs Q4826371.
- Autologous_patient_specific_tumor_antigen_response sameAs Q4826371.
- Autologous_patient_specific_tumor_antigen_response sameAs Autologous_patient_specific_tumor_antigen_response.
- Autologous_patient_specific_tumor_antigen_response wasDerivedFrom Autologous_patient_specific_tumor_antigen_response?oldid=590720833.
- Autologous_patient_specific_tumor_antigen_response isPrimaryTopicOf Autologous_patient_specific_tumor_antigen_response.